Meridian Bioscience, Inc. (VIVO) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.65 +2.20%
Financial Fact:
Total other income (expense): -143K
Today's EPS Names:
CCEL, FNGR, FAST, More
Financial Fact:
Total other income (expense): -143K
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q4 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $43.7 million versus the consensus estimate of $42.97 million.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- First Bancorp to acquire First Carolina Bancshares for $166M
- Goldman Sachs on JPMorgan (JPM): 'We believe the results were modestly positive'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
